Blog

  • Barry Sheerman – 2016 Parliamentary Question to the Home Office

    Barry Sheerman – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Barry Sheerman on 2016-01-26.

    To ask the Secretary of State for the Home Department, what plans she has to negotiate an extradition treaty with Pakistan.

    James Brokenshire

    Between 1 January 2010 and 31 December 2015 there were no extraditions from Pakistan to the UK.

    There is no bilateral extradition treaty between the UK and Pakistan and, unless a multilateral convention applies, extradition is on the basis of reciprocity.

    The Government will neither confirm nor deny whether it is considering or is involved in negotiations with a particular country regarding an extradition treaty.

  • Barry Sheerman – 2016 Parliamentary Question to the Home Office

    Barry Sheerman – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Barry Sheerman on 2016-01-26.

    To ask the Secretary of State for the Home Department, under what arrangements people can be extradited from Pakistan to the UK.

    James Brokenshire

    Between 1 January 2010 and 31 December 2015 there were no extraditions from Pakistan to the UK.

    There is no bilateral extradition treaty between the UK and Pakistan and, unless a multilateral convention applies, extradition is on the basis of reciprocity.

    The Government will neither confirm nor deny whether it is considering or is involved in negotiations with a particular country regarding an extradition treaty.

  • Barry Sheerman – 2016 Parliamentary Question to the Home Office

    Barry Sheerman – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Barry Sheerman on 2016-01-26.

    To ask the Secretary of State for the Home Department, how many people have been extradited from Pakistan to the UK in each of the last five years.

    James Brokenshire

    Between 1 January 2010 and 31 December 2015 there were no extraditions from Pakistan to the UK.

    There is no bilateral extradition treaty between the UK and Pakistan and, unless a multilateral convention applies, extradition is on the basis of reciprocity.

    The Government will neither confirm nor deny whether it is considering or is involved in negotiations with a particular country regarding an extradition treaty.

  • Barry Sheerman – 2016 Parliamentary Question to the Home Office

    Barry Sheerman – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Barry Sheerman on 2016-01-26.

    To ask the Secretary of State for the Home Department, how many people have been extradited from India to the UK in each of the last five years.

    James Brokenshire

    Between 1 January 2010 and 31 December 2015, the UK has extradited one person from India. This extradition took place in 2013.

  • Barry Sheerman – 2016 Parliamentary Question to the Home Office

    Barry Sheerman – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Barry Sheerman on 2016-01-26.

    To ask the Secretary of State for the Home Department, how many people have been extradited from Bangladesh to the UK in each of the last five years.

    James Brokenshire

    Between 1 January 2010 and 31 December 2015 the UK has extradited two people from Bangladesh. These extraditions occurred in 2010 and in 2011.

  • Rosie Cooper – 2016 Parliamentary Question to the Home Office

    Rosie Cooper – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Rosie Cooper on 2016-01-26.

    To ask the Secretary of State for the Home Department, whether the information that a person has been arrested and bailed and subsequently released without charge by the Police is required to be provided to the Disclosure and Barring Service (DBS); how long such information is required to remain on that individual’s DBS records; and for how long the DBS is required to disclose that information to enquirers.

    Karen Bradley

    A chief police officer should only provide such information to the Disclosure and Barring Service (DBS) for inclusion in an enhanced criminal record certificate where they believe it is relevant to the purpose of the certificate and, in their opinion, it ought to be included.

    The DBS does not maintain a record itself for disclosure purposes.

  • Gordon Marsden – 2016 Parliamentary Question to the Department of Health

    Gordon Marsden – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Gordon Marsden on 2016-01-26.

    To ask the Secretary of State for Health, what steps he is taking to ensure that injured military veterans do not have to pay social care costs out of their military compensation; and if he will make a statement.

    Alistair Burt

    Armed forces veterans injured in service receive payments either through the War Disablement Pension (WDP) or the Armed Forces Compensation Scheme (AFCS). The AFCS applies to veterans injured from 6 April 2005. These payments are divided into a personal injury compensation element and other payments. Traditionally, only the personal injury compensation payment has been fully disregarded.

    Since October 2012 Guaranteed Income Payments made to veterans under the AFCS have been disregarded. The Department has been in discussion with the Royal British Legion about how WDP payments are treated. Currently the first £10 per week of WDP payments is disregarded. The Government is considering how WDP payments to veterans should be treated in the financial assessment for social care charging in future.

  • Gareth Thomas – 2016 Parliamentary Question to the Department of Health

    Gareth Thomas – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Gareth Thomas on 2016-01-26.

    To ask the Secretary of State for Health, what assistance his Department has offered to Harrow Clinical Commissioning Group to help it avoid its projected deficit of £116.4 million by 2018-19; and if he will make a statement.

    Alistair Burt

    We are advised by NHS England that the projected deficit figure for 2018/19 dates from November 2013, and was included in a potential “downside case” modelled as part of Harrow Clinical Commissioning Group’s (CCG) sustainability plan which was submitted to NHS England.

    We understand that the sustainability plan also included an “upside case” and a “mid case” and that all three cases were modelled according to varying projected levels of Quality, Innovation, Productivity and Prevention (QIPP) savings.

    The joint financial strategy agreed with the seven other CCGs in north-west London, combined with higher than average growth in allocations and delivery of its QIPP programme, has enabled Harrow CCG to improve its financial performance, as a result of which it is now reporting a surplus of £2 million for 2015/16.

    For 2014/15, Harrow CCG received one of the highest funding increases in the country, amounting to 4.2% on the previous year. For 2015/16, the CCG received another above average increase in allocation and will receive a funding increase of 6% in 2016/17, compared to an average CCG growth figure in London of 3.6%.

  • Mark Durkan – 2016 Parliamentary Question to the Department of Health

    Mark Durkan – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Mark Durkan on 2016-01-26.

    To ask the Secretary of State for Health, what estimate he has made of additional dialysis beds and staff costs to the NHS in the event of NICE’s review of TA 85 [ID456] of immunosuppressant agents for kidney transplant is upheld.

    George Freeman

    We have made no such estimate.

    The National Institute for Health and Care Excellence (NICE) is currently updating its technology appraisal guidance on immunosuppressive therapy for kidney transplant in adults. NICE consulted on its draft recommendations in August 2015 and published its final draft recommendations in December. NICE currently expects to publish its final guidance later this year.

    It will be for local National Health Service organisations to consider the impact of the NICE recommendations following guidance publication. NICE will publish a resource impact assessment alongside its guidance to support local implementation of its recommendations.

  • Tom Brake – 2016 Parliamentary Question to the Department of Health

    Tom Brake – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Tom Brake on 2016-01-26.

    To ask the Secretary of State for Health, what proportion of the NHS’ budget is spent on research and campaigns on (a) gender-specific cancers and (b) fertility treatment.

    George Freeman

    National Health Service revenue expenditure was £110.6 million in 2014/15.

    The Department funds the National Institute for Health Research (NIHR) to provide a health research system in which the NHS supports outstanding individuals working in world-class facilities, conducting leading-edge research focused on the needs of patients and the public. Information on total NIHR spend on research on gender-specific cancers and on fertility treatment is not available. Spend on research funded directly by the NIHR is categorised by Health Research Classification System (HRCS) health categories including ‘cancer’ and ‘reproductive health and childbirth’. There are no HRCS health sub-categories, such as for gender-specific cancers or fertility treatment.

    NHS England has advised that information on campaigns spending by NHS organisations is not collected centrally.

    Public Health England (PHE) has run gender-specific campaigns on breast cancer in women over 70, ovarian cancer and prostate cancer in black men as part of Be Clear on Cancer. Information on media spending for these campaigns in each of the last three complete financial years is shown in the table.

    2012/13 £ million

    2013/14 £ million

    2014/15 £ million

    Breast 70+

    0.50

    1.48

    –

    Ovarian

    0.44

    0.57

    –

    Prostate

    –

    –

    0.07

    Source: PHE

    Notes:

    Figures are net plus agency fees and commissions (rounded to nearest £10,000). Figures exclude VAT and Central Office of Information fees.

    Media spend includes expenditure for advertising on Television, Radio, National Press, Regional Press, Out of Home (Outdoor), Cinema and Digital.